ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
0.00%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,417.715
-0.15%
Brent Oil
81.795
-0.79%
Bitcoin
69,773.30
-0.51%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Indivior PLC (INDV)

  7. Indivior PLC (INDV) News

Indivior (INDV)

Indivior PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INDV
DateTimeSourceHeadlineSymbolCompany
21/05/202411:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
20/05/202415:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
13/05/202413:28Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
09/05/202416:49Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
09/05/202411:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:INDVIndivior PLC
25/04/202407:00PR Newswire (US)Indivior Announces Q1 2024 Financial ResultsNASDAQ:INDVIndivior PLC
11/03/202418:43PR Newswire (US)Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal NaloxoneNASDAQ:INDVIndivior PLC
29/02/202407:02PR Newswire (US)Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict LitigationNASDAQ:INDVIndivior PLC
22/02/202407:00PR Newswire (US)Indivior Announces Q4 / FY 2023 Financial ResultsNASDAQ:INDVIndivior PLC
09/11/202307:05PR Newswire (US)Indivior Announces Q3 2023 Financial ResultsNASDAQ:INDVIndivior PLC
09/11/202307:05PR Newswire (US)Indivior Announces Q3 2023 Financial ResultsNASDAQ:INDVIndivior PLC
11/10/202321:20PR Newswire (US)Indivior Enters an Exclusive Licensing Agreement with Alar PharmaceuticalsNASDAQ:INDVIndivior PLC
26/09/202319:30PR Newswire (US)Indivior Publishes Real World Data Showing SUBLOCADE® May Reduce Non-Fatal Overdoses Among Individuals with Opioid Use Disorder in CanadaNASDAQ:INDVIndivior PLC
21/08/202307:02PR Newswire (US)Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation ClaimsNASDAQ:INDVIndivior PLC
21/08/202307:02PR Newswire (US)Indivior Reaches Agreement with End Payor Class to Resolve Their Antitrust Multi-District Litigation ClaimsNASDAQ:INDVIndivior PLC
27/07/202307:00PR Newswire (US)Indivior Announces Q2/H1 2023 Financial ResultsNASDAQ:INDVIndivior PLC
14/06/202318:53PR Newswire (US)Indivior Announces Four Abstracts Accepted for Presentation at the 85th Annual Scientific Meeting of the College on Problems of Drug DependenceNASDAQ:INDVIndivior PLC
 Showing the most relevant articles for your search:NASDAQ:INDV

Your Recent History

BTRX
METADIUMBTC
Metadium
AMEX
TPET
Trio Petroleum
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved